Call for Abstract

International Conference on Fibromyalgia and Chronic Pain, will be organized around the theme “Recent trends, advancements and discoveries on Fibromyalgia and Chronic pain”

Fibromyalgia 2016 is comprised of 12 tracks and 85 sessions designed to offer comprehensive sessions that address current issues in Fibromyalgia 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Chronic pain is often defined as any pain lasting more than 12 weeks. Whereas acute pain is a normal sensation that alerts us to possible injury, chronic pain is very different. Chronic pain persists often for months or even longer.

  • Track 1-1Peripheral neuropathy
  • Track 1-2Headache pain
  • Track 1-3Muscle spasm
  • Track 1-4Chronic pain medications
  • Track 1-5Arthritis
  • Track 1-6Research on Devices
  • Track 1-7Rheumatology
  • Track 1-8Myalgic Encephalomyelitis

Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. Researchers believe that fibromyalgia amplifies painful sensations by affecting the way your brain processes pain signals.

  • Track 2-1Biofeedback
  • Track 2-2Feline Fibromyalgia
  • Track 2-3Fibromyalgia among genders
  • Track 2-4Polymyalgia
  • Track 2-5Medication
  • Track 2-6Cachexia
  • Track 2-7Sarcopenia
  • Track 2-8Fibromyalgia in children
  • Track 2-9Pathophysiology

The defining symptoms of fibromyalgia are chronic widespread pain, fatigue, sleep disturbance, and heightened pain in response to tactile pressure Other symptoms may include tingling of the skin prolonged muscle spasms, weakness in the limbs, nerve pain, muscle twitching, palpitations, and functional bowel disturbances.

  • Track 3-1Muscle Abnormalities
  • Track 3-2Multiple Chemical Sensitivity
  • Track 3-3Sleep Apnea
  • Track 3-4Neurally Mediated Hypotension (NMH)
  • Track 3-5Depression Irritable Bowel Syndrome (IBS)
  • Track 3-6Restless Legs Syndrome (RLS)
  • Track 3-7Nociceptive Pain Psychogenic
  • Track 3-8Pain Visceral Pain
  • Track 3-9General Somatic Pain
  • Track 3-10Neuropathic Pain Bone Pain

Fibromyalgia syndrome (FMS), chronic fatigue syndrome (CFS), multiple chemical sensitivity syndromes (MCS), myofascial pain syndrome (MPS), and other conditions form a family of overlapping syndromes.

  • Track 4-1Autonomic Nervous System
  • Track 4-2Nonpharmacologic Treatment Options
  • Track 4-3Pharmacotherapy for Patients With Fibromyalgia
  • Track 4-4Neuroendocrine Abnormalities
  • Track 4-5Cerebrospinal fluid abnormalities
  • Track 4-6Multiple chemical sensitivity syndrome
  • Track 4-7Myofascial pain syndrome Rhematology

The cause of fibromyalgia is unknown. However, several hypotheses have been developed including "central sensitization". This theory proposes that people with fibromyalgia have a lower threshold for pain because of increased reactivity of pain-sensitive nerve cells in the spinal cord or brain

  • Track 5-1Neurological Depression
  • Track 5-2Psychological and social ailments
  • Track 5-3Musculoskeletal
  • Track 5-4Stress, Pressure, Tension, Work, and Depression

Fibromyalgia is a syndrome with multiple symptoms that commonly occur together, including widespread pain, decreased pain threshold or tender points, incapacitating fatigue, and anxiety or depression. Most laboratory tests are not very useful by themselves for diagnosing fibromyalgia.

  • Track 6-1Rheumatological
  • Track 6-2Endocrine
  • Track 6-3Infectious
  • Track 6-4Malignancy
  • Track 6-5History: Functional & Psychological

Poor lifestyles including being a smoker, obesity and lack of physical activity may increase the risk of an individual developing fibromyalgia. Physical and Psychological approaches could help in managing the pain and also acts as a tool to supress the secondary problems caused by the pain.

  • Track 7-1Lifestyle Changes
  • Track 7-2Treating Fibromyalgia in the Presence of Psychiatric Symptoms
  • Track 7-3Physical and Occupational Therapy
  • Track 7-4Psychological causes
  • Track 7-5Cognitive behavioural therapy
  • Track 7-6Natural therapies
  • Track 7-7Non Pharmacological treatments
  • Track 7-8Chiropractic

Genetic factors can explain a significant amount of the variability in the perception of pain. Fibromyalgia syndrome and related conditions are syndromes characterized by generalized pain sensitivity as well as a constellation of other symptoms. Family studies show a strong familial aggregation of FMS and related conditions, suggesting the importance of genetic factors in the development of these conditions.

  • Track 8-1Hereditary Genes
  • Track 8-2Stress pathway
  • Track 8-3Distress pathway
  • Track 8-4Family

Novel approaches could be of any individual treatment or a group of complex factors that could treat and manage the pain caused by the chronic pain syndrome. The life style, food habits, drug abuse, psychological approaches also key factors to help in management of chronic pain.

  • Track 9-1Exercise
  • Track 9-2Accupuncture
  • Track 9-3Healthy Diet
  • Track 9-4Physical therapy
  • Track 9-5Meditation
  • Track 9-6Sleep Pattern
  • Track 9-7Stress Reduction
  • Track 9-8Yoga
  • Track 9-9Shockwave Therapy

Interventional pain management or interventional pain medicine is a subspecialty of the medical specialty, pain management, devoted to the use of invasive techniques such as facet joint injections, nerve, neuroaugmentation, vertebroplasty, kyphoplasty, nucleoplasty, endoscopic discectomy, percutaneous spine fusion and implantable drug delivery systems.

  • Track 10-1Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Track 10-2Opioid
  • Track 10-3Analgesics
  • Track 10-4Adjuvant Therapies
  • Track 10-5Muscle Relaxants
  • Track 10-6Painkillers
  • Track 10-7Opiods Side effects of medicines
  • Track 10-8Anticonvulsants
  • Track 10-9Narcotics
  • Track 10-10Antidepressants

Developments in the understanding of the pathophysiology of the disorder have led to improvements in treatment, which include prescription medication, behavioural intervention and exercise. Indeed, integrated treatment plans that incorporate medication, patient education, aerobic exercise and cognitive-behavioural therapy have been shown to be effective in alleviating pain and other fibromyalgia-related symptoms.

  • Track 11-1Localised intramuscular injection
  • Track 11-2Scar Infiltration
  • Track 11-3Peripheral nerve blocks
  • Track 11-4Joint injections
  • Track 11-5Regional blocks
  • Track 11-6Sympathetic blocks

Advances in understanding of the growing number of pathophysiologic mechanisms that underlie the generation of pain and the influence of the brain on the experience of pain led to the investigation of numerous compounds for treating pain. Improved knowledge of the subjective nature of pain, the variations in the measurement of pain, the mind-body placebo effect and the impact of differences in the conduct of a clinical trial on the outcome have changed approaches to design and implement studies. Careful consideration of how these concepts affect the choice of study population, the randomization and blinding process, the measurement and collection of data, and the analysis and interpretation of results should improve the quality of clinical trials for potential pain therapies.

  • Track 12-1Dopamine dysfunction
  • Track 12-2Serotonin metabolism
  • Track 12-3Poly-modal sensitivity
  • Track 12-4Neuroendocrine disruption
  • Track 12-5Sympathetic hyperactivity